Cipher Pharmaceuticals Inc. (CPHRF) Financials
CPHRF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 167.8 million | 21.9 million |
| June 30, 2026 | 156.7 million | 19.6 million |
| March 31, 2026 | 153.8 million | 20.6 million |
| Dec. 31, 2025 | 156.2 million | 30.2 million |
CPHRF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 8.3 million | ? |
| June 30, 2026 | 3.0 million | ? |
| March 31, 2026 | 4.5 million | 304000 |
| Dec. 31, 2025 | 8.8 million | 525000 |
CPHRF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | 10.7 million |
| June 30, 2026 | 3.9 million |
| March 31, 2026 | 6.2 million |
| Dec. 31, 2025 | 13.5 million |
CPHRF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 15.3 million | - | 339010 |
| June 30, 2026 | 9.1 million | - | 124850 |
| March 31, 2026 | 6.4 million | - | 428542 |
| Dec. 31, 2025 | 7.5 million | 5.0 million | 504606 |
CPHRF Shares Outstanding
CPHRF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 4777 | 17697 | 3.3 million | - |
| June 30, 2026 | 15528 | - | 3.4 million | - |
| March 31, 2026 | 987 | - | 2.9 million | 499000 |
| Dec. 31, 2025 | 25433 | - | 4.0 million | - |
CPHRF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 12.5 million | 4.1 million |
| June 30, 2026 | 11.8 million | 4.0 million |
| March 31, 2026 | 12.3 million | 4.0 million |
| Dec. 31, 2025 | 12.4 million | 4.2 million |
CPHRF
Price: $9.25
52 week price:
Earnings Per Share: 0.67 USD
P/E Ratio: 16.42
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 244.5 million